California Hepatitis C Task Force

California Hepatitis C Task Force The California Hepatitis C Task Force will develop and improve HCV prevention, education, treatment, testing and reporting practices.

We will support policy that removes barriers and improves the quality and access to care for all Californians. The California Hepatitis C Task Force will develop models and improve existing HCV prevention, education, treatment, testing and reporting practices. We will support policy that removes barriers and provides incentives to improve the quality of patient centered care, prevents new incidenc

es of chronic hepatitis and promotes best practices for the delivery of evidence based treatments for viral hepatitis.

New research highlights that gender-affirming care leads to better HIV outcomes for transgender individuals. Access to s...
07/07/2025

New research highlights that gender-affirming care leads to better HIV outcomes for transgender individuals. Access to such care is crucial for improving health equity and combating HIV in LGBTQ+ communities. Learn more:

HIV prevalence went down and viral suppression went up as more people used gender-affirming hormone therapy.

Bridgette J. Picou, LVN, ACLPN, is a powerful voice in HIV advocacy; as a Black woman and nurse living with HIV, she bri...
07/02/2025

Bridgette J. Picou, LVN, ACLPN, is a powerful voice in HIV advocacy; as a Black woman and nurse living with HIV, she bridges the gap between clinical care and lived experience. Her work challenges stigma and ensures women are heard. Learn more:

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

New hope in the fight against HIV: A multi-step vaccine strategy shows promise in creating long-lasting immunity by prod...
06/30/2025

New hope in the fight against HIV: A multi-step vaccine strategy shows promise in creating long-lasting immunity by producing powerful antibodies that could block even the most stubborn HIV strains. Learn more:

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies capable of blocking a wide range of HIV strains-including those that are typically the hardest to st...

A study reveals an increase in PrEP prescriptions among U.S. young adults aged 18–25 from 2016 to 2023. While this surge...
06/27/2025

A study reveals an increase in PrEP prescriptions among U.S. young adults aged 18–25 from 2016 to 2023. While this surge is encouraging, researchers note a decline in consistent usage, highlighting the need for improved adherence strategies. Learn more:

Eight times more American young adults now take medication to protect them from HIV than a decade ago, a new study finds.

U.S. cuts to HIV funding in Uganda led to clinic closures and disrupted access to life-saving medications, forcing famil...
06/25/2025

U.S. cuts to HIV funding in Uganda led to clinic closures and disrupted access to life-saving medications, forcing families to withdraw children from school due to lack of treatment. While some services resumed, the future of HIV care is still uncertain:

The Rakai Health Sciences Program transformed global AIDS policies and cut new cases by 90%. How will its storied research and clinical legacy continue?

Mila Clarke, a type 1 diabetes patient advocate and nutrition diabetes health coach, shares insight about the way she ha...
06/23/2025

Mila Clarke, a type 1 diabetes patient advocate and nutrition diabetes health coach, shares insight about the way she handles cravings when her blood sugar is high. “The key for me is not to demonize the craving.” Learn more:

Mila Clarke, an integrative nutrition diabetes health coach with type 1 diabetes, shares the tactics that work for her.

06/20/2025

New research confirms that type 2 diabetes can be reversed without insulin through targeted lifestyle changes such as weight loss, dietary adjustments, and increased physical activity. Early intervention is crucial for achieving remission. Learn more:

A diabetes drug, pioglitazone, shows promise in slowing prostate cancer progression. By targeting the PPARγ protein, it ...
06/18/2025

A diabetes drug, pioglitazone, shows promise in slowing prostate cancer progression. By targeting the PPARγ protein, it may reduce tumor growth and recurrence. This finding opens doors for repurposing existing medications in cancer therapy. Learn more:

Drugs targeting PPARγ may reduce the likelihood of prostate cancer recurrence in patients with type 2 diabetes.

Women are often diagnosed with type 2 diabetes later than men due to biological factors like hormonal changes during pre...
06/16/2025

Women are often diagnosed with type 2 diabetes later than men due to biological factors like hormonal changes during pregnancy and menopause. Sex-specific diagnostic approaches and lifelong screening are needed to improve detection in women. Learn more:

Researchers are trying to understand more about the biological and social differences that contribute to later diabetes diagnoses and worse outcomes in women.

Pharmacists are uniquely positioned to close hepatitis A & B vaccination gaps. By offering extended hours and walk-in se...
06/13/2025

Pharmacists are uniquely positioned to close hepatitis A & B vaccination gaps. By offering extended hours and walk-in services, pharmacies have increased vaccination rates by over 30%. Learn more:

President of the National Foundation for Infectious Diseases, Jeff Goad, PharmD, MPH, discusses how pharmacists can help improve hepatitis A and B vaccine rates across the country.

Vermont has one of the highest rates of new hepatitis C infections in the U.S., yet many remain unaware they're infected...
06/11/2025

Vermont has one of the highest rates of new hepatitis C infections in the U.S., yet many remain unaware they're infected. Experts emphasize the importance of getting tested—early detection can prevent liver failure, cancer, and even death. Learn more:

Vermont has high rates of a dangerous infection, but there are ways to get you and your family tested.

Concerned about vaccine ingredients? Hepatitis A & B vaccines have been extensively tested and are safe. Don't let misin...
06/09/2025

Concerned about vaccine ingredients? Hepatitis A & B vaccines have been extensively tested and are safe. Don't let misinformation put your health at risk. Learn more:

Jeff Goad, PharmD, MPH, discusses hesitancy for hepatitis vaccines and the necessary advice pharmacists can utilize to help patients manage these misconceptions.

Address

Petaluma, CA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 10am - 8pm
Sunday 11am - 7pm

Alerts

Be the first to know and let us send you an email when California Hepatitis C Task Force posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share